drugset

drugset / Trial / NCT00310700

Kinetics of B Cell Response in Infants Menjugate Vaccination

NCT00310700 ↗

Phase 4 Completed 75 enrolled Novartis Novartis Vaccines · collab

Non-randomizedSingle-groupOpen-labelPrevention

Summary

Kinetics of B cell response in infants Menjugate vaccination

Timeline

Start: 2005-05
Primary completion: 2005-11
Completion: 2005-11

Publications

Background Kelly DF, Snape MD, Perrett KP, Clutterbuck EA, Lewis S, Blanchard Rohner G, Jones M, Yu LM, Pollard AJ. Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine. Immunology. 2009 May;127(1):134-43. doi: 10.1111/j.1365-2567.2008.02934.x.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Menjugate	Vaccine	—	—

Indications